Vaccine | Year Diff | Region | Total | |||||
Amazon | Andean | Bogotá | Caribbean | Eastern Plains | Pacific | |||
MMR reinf | 2019 | 70.7 | 77.6 | 81.4 | 72.4 | 72.8 | 68.6 | 73.2 |
2020 | 53.3 | 67.9 | 80.5 | 65.5 | 59.8 | 53.2 | 62.2 | |
Diff | 17.4 | 9.7 | 0.9 | 6.9 | 13.0 | 15.4 | 10.9 | |
OPV second reinf | 2019 | 70.3 | 77.4 | 80.4 | 72.5 | 72.4 | 69.0 | 73.1 |
2020 | 53.0 | 66.9 | 79.0 | 65.5 | 59.2 | 52.2 | 61.7 | |
Diff | 17.4 | 10.5 | 1.4 | 7.0 | 13.3 | 16.8 | 11.4 | |
DPT second reinf | 2019 | 70.4 | 77.3 | 80.7 | 72.2 | 72.4 | 68.6 | 72.9 |
2020 | 53.0 | 68.1 | 82.8 | 66.5 | 60.0 | 53.3 | 62.7 | |
Diff | 17.4 | 9.2 | −2.1 | 5.6 | 12.4 | 15.3 | 10.2 |
Diff, 2019–2020 difference; DPT, diphtheria, pertussis and tetanus; MMR, measles, mumps and rubella; OPV, oral polio vaccine; reinf, reinforcement.